FDA Inspection 1257638 — Stanford Blood Center LLC

Stanford Blood Center LLC — FEI 3000210612

The FDA completed an inspection of Stanford Blood Center LLC on December 17, 2024 in Mountain View, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
December 17, 2024
Fiscal Year
2025
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Mountain View, CA (United States)